What Torray Funds bought and sold in Q4 2024
In Q4 2024, Torray Funds (Torray Funds) opened 3 new positions — including CEG (0.8%), FCN (0.2%), WFC (<0.1%), added to 9, trimmed 8, exited 5 (MTN, AZPN1USD, CHD). The book stood at $697M across 101 positions, filed Feb 6, 2025.
3New9Added8Trimmed5Exited
New positions (3)
Added to (9)
- AMGNAmgen Inc+395% shares · 2.2% · $16M
- HPEHewlett Packard Enterprise+285% shares · 2.2% · $15M
- SNPSSynopsys Inc+39% shares · 1.1% · $8M
- ABBVAbbvie Inc+42% shares · 0.8% · $5M
- UNPUnion Pacific Corp+33% shares · 0.7% · $5M
- CNACna Financial Corp+27% shares · 0.6% · $4M
- LMTLockheed Martin Corp+30% shares · 0.6% · $4M
- RCKTRocket Pharmaceuticals Inc+66% shares · 0.2% · $2M
- AXSMAxsome Therapeutics Inc+45% shares · 0.2% · $1M
Trimmed (8)
- RPRXRoyalty Pharma Plc-20% shares · 2.5% · $17M
- UNHUnitedhealth Group Inc-20% shares · 1.6% · $11M
- QCOMQualcomm Inc-25% shares · 1.4% · $10M
- MSMorgan Stanley-21% shares · 0.7% · $5M
- SHWSherwin-williams Co/the-21% shares · 0.6% · $4M
- UPSUnited Parcel Service-cl B-34% shares · 0.4% · $3M
- NTRANatera Inc-29% shares · 0.3% · $2M
- HONHoneywell International Inc-97% shares · 0.1% · $352K
Exited (5)
Torray Funds's other filings
Changes vs the prior quarter's 13F, long US equity positions only (no shorts, options, or non-US listings). ADD/TRIM are share- count changes of ±20% or more. Sourced from SEC EDGAR. Not investment advice.